|
|
|
Volumn 146, Issue 31, 2002, Pages 1445-1448
|
|
Thalidomide in the treatment of refractory multiple myeloma: A Dutch study of 72 patients revealed an antitumour effect in 45%;Thalidomide als behandeling voor refractair multipel myeloom in een Nederlandse studie onder 72 patiënten: Een antitumoreffect bij 45%
a
a
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DEXAMETHASONE;
THALIDOMIDE;
ANTINEOPLASTIC AGENT;
MULTIPLE MYELOMA M PROTEINS;
MULTIPLE MYELOMA M-PROTEINS;
PARAPROTEIN;
ADULT;
AGED;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CONSTIPATION;
CONTROLLED STUDY;
DOSE RESPONSE;
DROWSINESS;
DRUG EFFECT;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG TOLERANCE;
FEMALE;
FOLLOW UP;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MAXIMUM PERMISSIBLE DOSE;
MULTIPLE MYELOMA;
POLYNEUROPATHY;
SOMNOLENCE;
SURVIVAL TIME;
TREATMENT OUTCOME;
TUMOR VOLUME;
VEIN THROMBOSIS;
VERTIGO;
MAXIMUM TOLERATED DOSE;
MIDDLE AGED;
MORTALITY;
RETROSPECTIVE STUDY;
SURVIVAL;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ENGLISH ABSTRACT;
FEMALE;
FOLLOW-UP STUDIES;
HUMAN;
MALE;
MAXIMUM TOLERATED DOSE;
MIDDLE AGE;
MULTIPLE MYELOMA;
MYELOMA PROTEINS;
RETROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
THALIDOMIDE;
TREATMENT OUTCOME;
HUMANS;
MIDDLE AGED;
|
|
EID: 0037014825
PISSN: 00282162
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (8)
|
|
References (15)
|
